Meditrial is a leading provider of clinical trial services and digital cloud-based solutions for the lifesciences industry. As a Clinical Research Organization (CRO), Meditrial is renowned as the go-to partner by companies developing breakthrough innovations that require a clearly defined path to first-in-man and pivotal clinical studies. Established in 2008, today Meditrial is a trusted resource for large corporations as well as start-ups requiring support and resources to execute trials in the Uniteef States and Europe. Headquartered in Zürich, Meditrial has offices in Berlin, Rome, London and New York.
Learm more: www.meditrial.net - www.catchtrial.com - www.mastertrial.com
Despite the everchanging regulation and increasing difficulty to obtain approval for clinical investigations, Meditrial has a remarkable record of 100% success in assisting clients to execute studies in medical centers of excellence throughout Europe and United States. Meditrial's software solutions allow customers to successfully manage large global trials and registries while monitoring the results in large number of patients.
Meditrial’s core strength lies in its clinical experts’ proficiency, alongside with its integrated digital platform for elearning, data capture and analytics. The organization provides a set of systems and tools to minimize complexity of clinical trials and regulatory approvals Meditrial is extremely proud to be one of the first—and very few—CROs certified by ISO 9001, ISO 13485 and ISO 27001 for information security.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Meditrial founded?
Meditrial was founded in 2008.
What industry is Meditrial in?
Meditrial operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Meditrial based?
Meditrial is headquartered in NEW YORK, United States.
Find investors for your startup like Meditrial
Gritt sends AI-personalised outreach to each investor — from your Gmail
